Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase IIa randomized double-blind placebo-controlled multiple ascending dose study of ABP2111Na tablets in overweight or obese adults
CTR20243414Phase 2Completed
- Sponsor
- EyeBio
- Start
- Sep 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ABP2111Na in obesity, Overweight, sponsored by EyeBio. Started Sep 2024; status: completed.
02
Drugs
ABP2111Na
03
Conditions
obesityOverweight
Beyond the preview
Go deeper on CTR20243414.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20243414.